跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AZACITIDINA GLENMARK 25 MG/ML POLVO PARA SUSPENSION INYECTABLE EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
AZACITIDINA GLENMARK 25 MG/ML POLVO PARA SUSPENSION INYECTABLE EFG
Approved
STANDARD
AZACITIDINA GLENMARK 25 MG/ML POLVO PARA SUSPENSION INYECTABLE EFG
Glenmark Arzneimittel Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 22, 2021
Approval ID
56f1d2043fb86ef7
Company
Glenmark Arzneimittel Gmbh
Type
Standard
Approval Details
Approval Id
56f1d2043fb86ef7
Drug Cima Aemps Name
AZACITIDINA GLENMARK 25 MG/ML POLVO PARA SUSPENSION INYECTABLE EFG
Register Number
86332
Holder Company Name
Glenmark Arzneimittel Gmbh
Marketing Company Name
Glenmark Farmaceutica S.L.U
Holder Company Detail Path
/organization/glenmark-arzneimittel-gmbh
Authorization Date
2021-10-22
Dosage Form
POLVO PARA SUSPENSIÓN INYECTABLE
Dose
25 mg/ml
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Glenmark Arzneimittel Gmbh
Company Detail Path
/organization/glenmark-arzneimittel-gmbh
Company Information
Pharmaceutical Company Name
Glenmark Arzneimittel GmbH
Country Name
Germany
Website
http://www.glenmark.de
Active Ingredients
AZACITIDINA
25 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 22, 2021
Approval ID
56f1d2043fb86ef7
Type
Standard
Back to CIMA-AEMPS Approvals